Psychotropic drug use among women exposed to intimate partner violence: A population-based study

Scandinavian Journal of Public Health

Volumn 38, Issue 5_suppl, 2010, Pages 88-95

  Stene, Lise Eilin ^a   Dyb, Grete ^b   Jacobsen, Geir Wenberg ^a   Schei, Berit ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Antidepressive agents; battered women; domestic violence; epidemiology; hypnotics and sedatives; mental health; psychological stress; psychotropic drugs; spouse abuse; women's health

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG UTILIZATION; FEMALE; HUMAN; LIFESTYLE; MENTAL STRESS; MIDDLE AGED; NORWAY; PARTNER VIOLENCE; PSYCHOLOGICAL ASPECT; PSYCHOSOMATIC DISORDER; QUESTIONNAIRE; SEXUAL CRIME; STATISTICS; WOMEN'S HEALTH;

ADULT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LIFE STYLE; MIDDLE AGED; NORWAY; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SEX OFFENSES; SPOUSE ABUSE; STRESS, PSYCHOLOGICAL; WOMEN'S HEALTH;

EID: 79952049355     PISSN: 14034948     EISSN: 16511905     Source Type: Journal    
DOI: 10.1177/1403494810382815     Document Type: Article

References (30)

1. Saltzman LE, Fanslow JL, McMahon PM and Shelley GA Intimate partner violence surveillance: uniform definitions and recommended data elements, Version 1.0. Atlanta (GA): National Center for Injury Prevention and Control, Centers for Disease Control and Prevention; 1999.
2. Neroien AI and Schei B. Partner violence and health: results from the first national study on violence against women in Norway. Scand J Public Health 2008; 36 (2): 161-8.
3. Krug EG, Dahlberg LL, Mercy JA, Zwi AB and Lozano R. World report on violence and health. Geneva: World Health Organization; 2002.
4. Garcia-Moreno C., Jansen HA, Ellsberg M., Heise L., Watts CH and WHO Multi-country Study Womens Health. Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence. Lancet 2006; 368 (9543): 1260-9.
5. Bonomi AE, Thompson RS, Anderson M., Reid RJ, Carrell D. and Dimer JA Intimate partner violence and women's physical, mental, and social functioning. Am J Prev Med 2006; 30 (6): 458-66.
6. Campbell JC Health consequences of intimate partner violence. Lancet 2002; 359 (9314): 1331-6.
7. Coker AL, Davis KE, Arias I., Desai S., Sanderson M., Brandt HM, et al. Physical and mental health effects of intimate partner violence for men and women. Am J Prev Med 2002; 23 (4): 260-8.
8. Ellsberg M., Jansen HA, Heise L., Watts CH, Garcia-Moreno C. and WHO Multi-country Study Womens Health. Intimate partner violence and women's physical and mental health in the WHO multi-country study on women's health and domestic violence: an observational study. Lancet 2008; 371 (9619): 1165-72.
9. Helweg-Larsen K. and Kruse M. Violence against women and consequent health problems: a register-based study. Scand J Public Health 2003; 31 (1): 51-7.
10. Dutton MA, Green BL, Kaltman SI, Roesch DM, Zeffiro TA and Krause ED Intimate partner violence, PTSD, and adverse health outcomes. J Interpers Violence 2006; 21 (7): 955-68.
11. Wuest J., Merrit-Gray M., Lent B., Varcoe C., Connors AJ and Ford-Gilboe M. Patterns of medication use among women survivors of intimate partner violence. Can J Public Health 2007; 98 (6): 460-4.
12. Romans SE, Cohen MM, Forte T., Du Mont J. and Hyman I. Gender and psychotropic medication use: the role of intimate partner violence. Prev Med 2008; 46 (6): 615-21.
13. Hausken AM, Skurtveit S., Rosvold EO, Bramness JG and Furu K. Psychotropic drug use among persons with mental distress symptoms: a population-based study in Norway. Scand J Public Health 2007; 35 (4): 356-64.
14. Ohayon MM and Lader MH Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63 (9): 817-25.
15. Alonso J., Angermeyer MC, Bernert S., Bruffaerts R., Brugha TS, Bryson H., et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 2004 (420): 55-64.
16. Ohayon MM, Caulet M., Priest RG and Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51 (3): 273-83.
17. Demyttenaere K., Bonnewyn A., Bruffaerts R., De Girolamo G., Gasquet I., Kovess V., et al. Clinical factors influencing the prescription of antidepressants and benzodiazepines: tesults from the European study of the epidemiology of mental disorders (ESEMeD). J Affect Disorders 2008; 110 (1-2): 84-93.
18. Kjosavik SR, Ruths S. and Hunskaar S. Psychotropic drug use in the Norwegian general population in 2005: data from the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2009; 18 (7): 572-8.
19. Linden M., Lecrubier Y., Bellantuano C., Benkert O., Kisely S. and Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 1999; 19 (2): 132-40.
20. Søgaard AJ and Selmer R. The Oslo Health Study. 2006. Available from: http://www.fhi.no/dav/bbb2a86ad7.doc (accessed 23 September 2009).
21. Sogaard AJ, Selmer R., Bjertness E. and Thelle D. The Oslo Health Study: the impact of self-selection in a large, population-based survey. Int J Equity Health 2004; 3 (1): 3.
22. Wijma B., Schei B. and Swanberg K. NorAQ: The NorVold abuse questionnaire. Division of Gender and Medicine, Faculty of Health Sciences, Linköping University; 2004.
23. Derogatis LR, Lipman RS, Rickels K., Uhlenhuth EH and Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci 1974; 19 (1): 1-15.
24. Strand BH, Dalgard OS, Tambs K. and Rognerud M. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nordic J Psychiatry 2003; 57 (2): 113-18.
25. Romans S., Forte T., Cohen MM, Du Mont J. and Hyman I. Who is most at risk for intimate partner violence? A Canadian population-based study. J Interpers Violence 2007; 22 (12): 1495-514.
26. Ellsberg M. and Heise L. Researching violence against women: a practical guide for researchers and activists. Washington DC, United States: World Health Organization, PATH; 2005.
27. Bonomi AE, Anderson ML, Rivara FP and Thompson RS Health care utilization and costs associated with physical and nonphysical-only intimate partner violence. Health Serv Res 2009; 44 (3): 1052-67.
28. Kernic MA, Wolf ME and Holt VL Rates and relative risk of hospital admission among women in violent intimate partner relationships. Am J Public Health 2000; 90 (9): 1416-20.
29. Plichta SB Intimate partner violence and physical health consequences: policy and practice implications. J Interpers Violence 2004; 19 (11): 1296-323.
30. McCauley JL, Amstadter AB, Danielson CK, Ruggiero KJ, Kilpatrick DG and Resnick HS Mental health and rape history in relation to non-medical use of prescription drugs in a national sample of women. Addict Behav 2009; 34 (8): 641-8.